RecruitingNot ApplicableNCT05455307
Efficacy and Safety of Allium Ureteral Stent for Treating Refractory Ureteral Stricture
Efficacy and Safety of Self-expanding Ureteral Stent for Treating Refractory Ureteral Stricture: Results of a Multicenter Experience
Sponsor
En Chu Kong Hospital
Enrollment
200 participants
Start Date
Jul 30, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
To conduct a prospective, multi-center study to observe the long-term efficacy and safety of self expanding ureteral stent for treating participants with refractory ureteral stricture.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria1
- refractory ureteral stricture after at least two times of ureteral dilation
Exclusion Criteria1
- poor cardiovascular function for anesthesia unwilling to accept the long-term placement of ureteral stent uncontrolled urinary tract infection
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEAllium ureteral stent
observe the effficacy and safety of long-term self expanding ureteral stents for treating refractory ureteral stricture
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05455307